Silence Therapeutics plc logo
Silence Therapeutics plc SLN
$ 17.83 0.85%

Annual report 2023
added 10-19-2024

report update icon

Silence Therapeutics plc Balance Sheet 2011-2024 | SLN

Annual Balance Sheet Silence Therapeutics plc

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

- - - - -42.7 M -39 M -51.9 M -16.9 M -15.9 M -8.91 M -3.69 M

Long Term Debt

- - - - - - - - - - - - -

Long Term Debt Current

179 K 446 K 137 K 341 K 287 K - - - - - - - -

Total Non Current Liabilities

- - - 51.3 M 15.5 M - - - - - - - -

Total Current Liabilities

- - - - - - - - - - - - -

Total Liabilities

- - - 76.9 M 25.2 M 3.83 M 2.66 M 1.61 M 1.12 M 2.01 M 1.72 M 959 K 1.26 M

Deferred Revenue

- - - - - - - - - - - - -

Retained Earnings

- - - -184 M -152 M -134 M -116 M -116 M -109 M -103 M -91.9 M -82.9 M -57.8 M

Total Assets

- - - 86 M 46.1 M 38.9 M 55 M 55.8 M 61.5 M 29.8 M 29.3 M 17.1 M 33.4 M

Cash and Cash Equivalents

54 M 54.8 M 73.5 M 27.4 M 13.5 M 21.5 M - - - - - - -

Book Value

- - - 9.06 M 20.9 M 35.1 M 52.4 M 54.2 M 60.4 M 27.8 M 27.6 M 16.1 M 32.2 M

Total Shareholders Equity

- - - 9.06 M 20.9 M 35.1 M - - - - - - -

All numbers in GBP currency

Quarterly Balance Sheet Silence Therapeutics plc

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - 72.5 M - - - 51.3 M - - - 15.5 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

- - - - -223 M - - - -184 M - - - -152 M - - - -134 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

- - - - 73.5 M - - - 27.4 M - - - 13.5 M - - - 21.5 M - - - 42.7 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Book Value

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

- - - - 8.53 M - - - 9.06 M - - - 20.9 M - - - 35.1 M - - - 52.4 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in GBP currency